Understanding how RPLP1 affects women's reproductive health issues
Dissecting the role of RPLP1 in female reproductive tract pathologies
This study is looking at a protein called RPLP1 in the lining of the uterus to understand how it affects cell communication and could lead to reproductive issues like endometriosis and adenomyosis, with the hope of finding new ways to help people facing fertility challenges.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-10705087 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called RPLP1 in the endometrium, the inner lining of the uterus, which is crucial for successful reproduction. It focuses on how changes in communication between endometrial cells can lead to reproductive disorders such as endometriosis and adenomyosis. By examining the effects of RPLP1 over-expression on cell behavior, the research aims to uncover mechanisms that contribute to these conditions and their associated symptoms. Patients may benefit from insights that could lead to new treatments or interventions for fertility-related issues.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing reproductive health issues such as endometriosis, adenomyosis, or infertility.
Not a fit: Patients who do not have any reproductive health issues or those who are not female may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for women suffering from reproductive tract pathologies.
How similar studies have performed: Other research has shown promising results in understanding the role of cellular communication in reproductive health, suggesting that this approach could yield valuable insights.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Nothnick, Warren B — University of Kansas Medical Center
- Study coordinator: Nothnick, Warren B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.